SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

SVB Leerink Maintains Outperform on Protagonist Therapeutics, Raises Price Target to $30

SVB Leerink maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Outperform and raises the price target from $17 to $30.

Benzinga · 05/22/2020 09:22

SVB Leerink maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Outperform and raises the price target from $17 to $30.